You are here

Why and How We Disclose Payments to Health Care Professionals

We want people to know, and understand, what we do: We want to be clear about our payments to health care providers and clinical investigators. Sharing this information helps patients and other interested parties to better understand these valuable relationships.

We have a record of communicating about what we do: This is a natural extension of our commitment to providing greater transparency into our business operations.

  • 2007: Pfizer led the industry by reporting its post-marketing commitments on
  • 2008: Pfizer began reporting its non-clinical grants and charitable contributions to patient, medical and scientific organizations.
  • 2009: Pfizer began collecting physician payment data for public reporting.

We report payments for a range of activities with physicians: We want patients to understand the way we work with health care professionals.

  • The payment reports on this website include payments to practicing physicians and other health care providers, as well as to principal investigators and institutions for Phase I-IV clinical trials sponsored by Pfizer, begun after July 1, 2009.
  • The reports on this website also include payments to major institutions for clinical trials ongoing as of July 1, 2009, and to principal investigators and all other entities for investigator-initiated research.
  • Pfizer also reports to the Centers for Medicare and Medicaid Services (CMS) payments and other transfers of value made to U.S.- licensed physicians and U.S. teaching hospitals. That information is available on the CMS site.
  • Because CMS reporting requirements differ from Pfizer’s, we encourage you to go this page for an explanation of the differences.